The Tel-Aviv Stock Exchange Ltd.
The Tel-Aviv Stock Exchange Ltd. (TVAVF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for The Tel-Aviv Stock Exchange Ltd. (TVAVF), covering cash flow, earnings, and balance sheets.
The Tel-Aviv Stock Exchange Ltd. (TVAVF) Income Statement & Financial Overview
View the income breakdown for The Tel-Aviv Stock Exchange Ltd. TVAVF across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $131.03M | $115.42M | $109.05M | $105.11M |
| Cost of Revenue | $63.09M | $70.21M | $58.94M | $51.81M |
| Gross Profit | $67.94M | $45.21M | $50.10M | $53.30M |
| Gross Profit Ratio | $0.52 | $0.39 | $0.46 | $0.51 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $4.47M | $6.14M | $4.15M | $3.08M |
| Operating Expenses | $21.37M | $13.91M | $50.10M | $22.93M |
| Total Costs & Expenses | $84.45M | $84.12M | $109.05M | $74.74M |
| Interest Income | $3.56M | $1.60M | $6.34M | $4.51M |
| Interest Expense | $2.67M | $1.84M | $2.30M | $2.51M |
| Depreciation & Amortization | $14.58M | $14.43M | $13.99M | $14.06M |
| EBITDA | $64.33M | $50.08M | $50.24M | $48.91M |
| EBITDA Ratio | $0.49 | $0.43 | $0.46 | $0.47 |
| Operating Income | $46.58M | $31.30M | $29.97M | $30.37M |
| Operating Income Ratio | $0.36 | $0.27 | $0.27 | $0.29 |
| Other Income/Expenses (Net) | $497000.00 | $2.51M | $3.98M | $1.98M |
| Income Before Tax | $47.08M | $33.81M | $33.94M | $32.34M |
| Income Before Tax Ratio | $0.36 | $0.29 | $0.31 | $0.31 |
| Income Tax Expense | $11.29M | $8.44M | $7.91M | $8.06M |
| Net Income | $35.79M | $25.37M | $26.03M | $24.28M |
| Net Income Ratio | $0.27 | $0.22 | $0.24 | $0.23 |
| EPS | $0.39 | $0.27 | $0.28 | $0.26 |
| Diluted EPS | $0.38 | $0.26 | $0.27 | $0.25 |
| Weighted Avg Shares Outstanding | $91.70M | $92.44M | $92.44M | $92.44M |
| Weighted Avg Shares Outstanding (Diluted) | $93.74M | $96.52M | $96.52M | $95.78M |
The company's financials show resilient growth, with revenue advancing from $105.11M in Q2 2024 to $131.03M in Q1 2025. Gross profit remained healthy with margins at 52% in Q1 2025 compared to 51% in Q2 2024. Operating income hit $46.58M last quarter, sustaining a consistent 36% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $64.33M. Net income rose to $35.79M, while earnings per share reached $0.39. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan